© 2004 by Oxford University Press
© 2004 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The American Cancer Society presented its 2004 Medal of Honor awards in February. Tony Hunter, Ph.D., received the society’s award for contributions in basic research. Hunter is a professor of molecular and cellular biology at the Salk Institute for Biological Studies in La Jolla, Calif. Hunter’s seminal contribution to cancer research was the discovery that many cellular proteins are tyrosine kinases that are often mutated and activated in different types of cancer. In December 2002, Hunter and his colleagues created a detailed map, called the Human Kinome Project, of the 518 protein kinase genes encoded by the human genome.
Dennis J. Slamon, M.D., Ph.D., received the society’s award for contributions in clinical research. Slamon is director of the Revlon/UCLA Women’s Cancer Research Program and head of clinical/transitional research at the University of California at Los Angeles Jonsson Comprehensive Cancer Center. Slamon and his colleagues conducted clinical and laboratory research that led to the development of the breast cancer drug Herceptin.
U.S. Secretary of Homeland Security Tom Ridge received the Society’s 2004 award for contributions in cancer control. He is a founding member of C-Change, formerly the National Dialogue on Cancer, and past chairman of its State Cancer Plans Team.
Sandra J. Horning, M.D., was elected as the president-elect of the American Society of Clinical Oncology. Horning is professor of medicine in the Divisions of Medical Oncology and Blood and Marrow Transplantation at Stanford University. She will begin her term on June 8 during the society’s 40th Annual Meeting in New Orleans.
Eugene Washington, M.D., has been appointed executive vice chancellor of the University of California at San Francisco Comprehensive Cancer Center. Washington is the chair of the Department of Obstetrics, Gynecology, and Reproductive Sciences.
He assumed his new post February 1 after the retirement of vice chancellor Regis Kelly, Ph.D., and will assume the responsibilities of vice chancellor for academic affairs on July 1, after the retirement of Dorothy Bainton, M.D.
Vincent Cryns, M.D., of the Robert H. Lurie Comprehensive Cancer Center, Chicago, received an Outstanding Junior Faculty Award from the Avon Foundation for achievements in breast cancer research. This $100,000 supplemental research award recognizes his discoveries that have affected breast cancer treatment.
Maurie Markman, M.D., has been appointed the first vice president for clinical research at the University of Texas M. D. Anderson Cancer Center, Houston.
Markman previously served as director of the Cleveland Clinic Taussig Cancer Center in Ohio. He also served as chair of the Department of Hematology/Oncology at the Cleveland Clinic Foundation and held appointments as a professor of medicine at Ohio State University School of Medicine.
The American Association for Cancer Research recently announced the recipients of two of its distinguished prizes.
Tony Hunter, Ph.D., received the Kirk A. Landon-AACR Prize for Basic Cancer Research. Hunter is a professor of molecular and cell biology at the Salk Institute for Biological Studies in La Jolla, Calif.
Raymond N. DuBois, M.D., Ph.D., was honored with the Dorothy P. Landon-AACR Prize for Translational Cancer Research. DuBois is the Hortense B. Ingram Professor of Molecular Oncology and the Vanderbilt-Ingram Cancer Center’s associate director for cancer prevention, control and population-based research, in Nashville, Tenn.
Both honorees received an unrestricted cash award of $200,000, and gave scientific lectures at the AACR Annual Meeting held in March in Orlando.
Edward A. Sausville, M.D., Ph.D., has been appointed associate director of clinical research at the University of Maryland Greenebaum Cancer Center, Baltimore, and will join the faculty of the University of Maryland School of Medicine.
Sausville is associate director of the National Cancer Institute’s Developmental Therapeutics Program. He will assume his new position in May.
Ellen Feigal, M.D., has joined the Translational Genomics Research Institute in Phoenix, Ariz., as its vice president of clinical sciences and deputy scientific director.
Feigal was the acting director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute.
John Mendelsohn, M.D., has been selected to receive the 27th annual Bristol-Myers Squibb Freedom to Discover Award for Distinguished Achievement in Cancer Research. He was recognized for his long-time leadership role in cancer education, research, and treatment and for his pivotal discoveries on inhibiting cancer cell growth.
Mendelsohn is the president of The University of Texas M. D. Anderson Cancer Center in Houston. The award, a $50,000 cash prize and a silver commemorative medallion, will officially be presented in October.
Bradley George, M.D., has been named medical director at Children’s at Scottish Rite at the AFLAC Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta.
George is a pediatric oncologist specializing in clinical care and research for high-risk solid tumors. Prior to joining Children’s, George was an associate of pediatric hematology/oncology with Geisinger Medical Center in Danville, Pa.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||